These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21532536)

  • 1. Brain amyloid imaging: the challenge of the third millennium.
    Pupi A; Mosconi L
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):223-4. PubMed ID: 21532536
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for brain amyloid imaging published.
    J Nucl Med; 2013 Mar; 54(3):13N. PubMed ID: 23457351
    [No Abstract]   [Full Text] [Related]  

  • 3. Getting a grip on Alzheimer's disease: imaging amyloid in the brain.
    van Berckel BN; Scheltens P
    Lancet Neurol; 2007 Mar; 6(3):204-6. PubMed ID: 17303523
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyloid PET scan: Staging beyond reading?
    Chételat G; Murray ME
    Neurology; 2017 Nov; 89(20):2029-2030. PubMed ID: 29046365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative Assessment in Amyloid-PET Imaging].
    Miwa K; Wagatsuma K; Yamao T; Kamitaka Y; Matsubara K; Akamatsu G; Imabayashi E
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(11):1165-1174. PubMed ID: 29151550
    [No Abstract]   [Full Text] [Related]  

  • 6. Isn't amyloid more than just a marker for Alzheimer disease?
    Killiany RJ
    Neurology; 2009 Oct; 73(15):1174-5. PubMed ID: 19741212
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer's disease: first-hand experience in Thailand.
    Thientunyakit T; Sethanandha C; Muangpaisan W; Chawalparit O; Arunrungvichian K; Siriprapa T; Thongpraparn T; Chanachai R; Gelovani J
    Nucl Med Commun; 2018 Feb; 39(2):186-192. PubMed ID: 29334579
    [No Abstract]   [Full Text] [Related]  

  • 8. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
    Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist.
    Klunk WE
    Arch Neurol; 2008 Oct; 65(10):1281-3. PubMed ID: 18852340
    [No Abstract]   [Full Text] [Related]  

  • 10. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
    Rinne JO; Wong DF; Wolk DA; Leinonen V; Arnold SE; Buckley C; Smith A; McLain R; Sherwin PF; Farrar G; Kailajärvi M; Grachev ID
    Acta Neuropathol; 2012 Dec; 124(6):833-45. PubMed ID: 23053137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.
    Lin KJ; Hsu WC; Hsiao IT; Wey SP; Jin LW; Skovronsky D; Wai YY; Chang HP; Lo CW; Yao CH; Yen TC; Kung MP
    Nucl Med Biol; 2010 May; 37(4):497-508. PubMed ID: 20447562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
    Förster S; Grimmer T; Miederer I; Henriksen G; Yousefi BH; Graner P; Wester HJ; Förstl H; Kurz A; Dickerson BC; Bartenstein P; Drzezga A
    Biol Psychiatry; 2012 May; 71(9):792-7. PubMed ID: 21679929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.
    Kadir A; Andreasen N; Almkvist O; Wall A; Forsberg A; Engler H; Hagman G; Lärksäter M; Winblad B; Zetterberg H; Blennow K; Långström B; Nordberg A
    Ann Neurol; 2008 May; 63(5):621-31. PubMed ID: 18300284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
    Huddleston DE; Small SA
    Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
    Klupp E; Grimmer T; Tahmasian M; Sorg C; Yakushev I; Yousefi BH; Drzezga A; Förster S
    J Nucl Med; 2015 Mar; 56(3):399-404. PubMed ID: 25678488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyloid-plaque imaging of the brain using PET].
    Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
    Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-phase amyloid PET: hitting two birds with one stone.
    Valentina G; Silvia M; Marco P
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1300-3. PubMed ID: 27105874
    [No Abstract]   [Full Text] [Related]  

  • 20. A tale of two tracers: the age of wisdom for dementia diagnosis?
    Johnson KA; Dickerson BC
    Neurology; 2011 Dec; 77(23):2008-9. PubMed ID: 22131545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.